Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients
Tsang, W.K.; Ho, Y.W.; Tong, K.L.; Chan, W.H.; Chan, A.
Transplantation Proceedings 28(3): 1330-1332
1996
ISSN/ISBN: 0041-1345 PMID: 8658681 Document Number: 459637
Document emailed within 1 workday
Related Documents
Massari, P.U.; Grosso, S.; de Boccardo, G.; Vásquez, M.C.; Schiavelli, R.O.; Sabbatiello, R.R.; Casadei, D.H.; Rial, M.C.; Jost, L.J.; Túrin, M.D.; Agost Carreño C, A.; Maggiora, E.C.; Gadea, M.M. 1996: A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group Transplantation Proceedings 28(6): 3365-3367Neumayer, H.H.; Färber, L.; Haller, P.; Kohnen, R.; Maibücher, A.; Schuster, A.; Vollmar, J.; Waiser, J. 1994: Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month Transplantation Proceedings 26(5): 2944-2948
Taesch, S.; Niese, D.; Mueller, E.A. 1994: Sandimmun neoral, a new oral formulation of cyclosporin a with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients Transplantation Proceedings 26(6): 3147-3149
Pethig, K.; Geiger, M.; Korn, A.; Grote, M.; Christians, U.; Wahlers, T. 1996: Follow-up after conversion to Neoral in stable heart transplant recipients Transplantation Proceedings 28(4): 2282-2284
Grant, D.; Rochon, J.; Levy, G. 1996: Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group Transplantation Proceedings 28(4): 2232-2233
Roth, D.; Miller, J. 1996: Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients Transplantation Proceedings 28(4): 2219
Johnson, E.M.; Zimmerman, J.; Duderstadt, K.; Chambers, J.; Sorenson, A.L.; Granger, D.K.; Almond, P.S.; Fryer, J.p.; Leventhal, J.R.; Scarola, J.; Matas, A.J.; Canafax, D.M. 1996: A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients Transplantation Proceedings 28(2): 987
Färber, L.; Maibücher, A.; Geissler, F.; Gutzler, F.; Wiesinger, F.O.; Winkler, M. 1994: Favourable clinical results of Sandimmun-Neoral in malabsorbing liver and heart transplant recipients Transplantation Proceedings 26(5): 2988-2993
Min, Z.L.; Zhao, M.; Zhu, Y.H.; Qi, J.; Wang, L.M.; Wang, Y.W. 1996: Experience with clinical use of Sandimmun Neoral in renal transplant patients Transplantation Proceedings 28(3): 1356-1357
Holt, D.W.; Mueller, E.A.; Kovarik, J.M.; van Bree, J.B.; Richard, F.; Kutz, K. 1995: Sandimmun neoral pharmacokinetics: impact of the new oral formulation Transplantation Proceedings 27(1): 1434-1437
Levy, G.A. 1996: Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral Transplantation Proceedings 28(4): 2252-2253
Odone, P.; Iberti, M. 1999: Switching to Neoral in patients with a stable kidney transplant. Retrospective study Minerva Urologica e Nefrologica 51(2): 79-83
Dotti, G.; Gaspari, F.; Caruso, R.; Perico, N.; Remuzzi, G.; Barbui, T.; Rambaldi, A. 2001: Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients Haematologica 86(3): 311-315
Neumayer, H.H.; Budde, K.; Färber, L.; Haller, P.; Kohnen, R.; Maibücher, A.; Schuster, A.; Vollmar, J.; Waiser, J.; Luft, F.C. 1996: Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year Clinical Nephrology 45(5): 326-331
Atkison, P.R.; Grant, D.R.; Williams, S.E.; Howard, J.; Wall, W.J.; Stiller, C.R. 1994: Sandimmune Neoral in paediatric liver transplant recipients with malabsorption of cyclosporin a Transplantation Proceedings 26(5): 2953-2954
Harmon, W.E.; Stablein, D.; Alexander, S.R.; Tejani, A. 1991: Graft thrombosis in pediatric renal transplant recipients. A report of the North American Pediatric Renal Transplant Cooperative Study Transplantation 51(2): 406-412
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350
Neuzillet, Y.; Cabaniols, L.; Karam, G.; Salomon, L.; Barrou, B.ît.; Petit, J.; Feuillu, B.ît.; Lechevallier, E. 2006: Study of urothelial bladder tumours in renal transplant recipients Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 16(3): 343-346
Bartucci, M.R. 1985: A comparative study of outpatient care as perceived by renal transplant recipients Anna Journal 12(2): 119-124
Babarykin, D.; Amerika, D.; Adamsone, I.; Valinietse, M.; Rosental, R. 1996: Transfer of patients with kidney grafts to Sandimmun Neoral normalizes the calcium level in erythrocyts Transplantation Proceedings 28(6): 3137